Oncaspar (pegaspargase) 3,750 IU/mL solution for injection, 5 mL vial — original (Austria) Acute lymphocytic leukemia (ALL) Targeted cancer therapy. Delivery of medications from Europe and beyond within 4-5 days. Storage conditions are met. Payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.
Interchangeable drugs with the same active ingredient:
Oncaspar, Hamsil
Indications
Oncaspar is indicated as a component of antineoplastic combination therapy for the reinduction of remission in acute lymphocytic leukemia (ALL) in children and adult patients with known hypersensitivity to native L-asparaginase.
- Trade Name:Oncaspar
- Chemical Name:pegasparagase
- Dosage:3750 IU/ml
- Form of Issue:Flacon
No reviews yet